Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical and microbiological effects of 2.5% acyclovir gel in chronic periodontitis
IRCT138801231809N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences Dental School
- Start
- Apr 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of aciclovir in chronic periodontitis, sponsored by Shiraz University of Medical Sciences Dental School. Primary endpoints: Clinical effects and Microbiological effects. Started Apr 2008; status: completed.
02
Drugs
aciclovir
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on IRCT138801231809N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138801231809N1.